BofA Securities: Najbardziej obiecujące akcje biotechnologiczne w 2023
- PrzezInvesting.com
- •
| Nazwa | Wol. | Cena | |
|---|---|---|---|
IBB iShares Nasdaq Biotechnology | 2,08M | 122,29-0,45% | 29/09 |
IBBQ Invesco Nasdaq Biotechnology | 4,32K | 19,82-0,45% | 29/09 |
| Nazwa | Wol. | Cena | |
|---|---|---|---|
ROIV Roivant Sciences Ltd | 17,22M | 11,68-6,93% | 29/09 |
SNDX Syndax Pharmaceuticals Inc | 9,84M | 14,52-7,10% | 29/09 |
NVAX Novavax Inc | 8,11M | 7,24+1,12% | 29/09 |
FGEN FibroGen Inc | 7,23M | 0,86-11,19% | 29/09 |
GRTS Gritstone Oncology Inc | 6,9M | 1,72+10,26% | 29/09 |
| Nazwa | Cena | |
|---|---|---|
EDIT Editas Medicine | 7,80 | +0,88 | +12,72%
CDXS Codexis | 1,89 | +0,19 | +11,18%
GRTS Gritstone Oncology | 1,72 | +0,160 | +10,26%
TARS Tarsus | 17,77 | +1,53 | +9,42%
TERN Terns Pharmaceuticals | 5,03 | +0,33 | +7,02%
| Nazwa | Cena | |
|---|---|---|
FHTX Foghorn | 5,00 | -0,83 | -14,24%
FGEN FibroGen Inc | 0,86 | -0,11 | -11,19%
NSTG NanoString Technologies | 1,72 | -0,18 | -9,47%
NKTX Nkarta | 1,39 | -0,11 | -7,33%
SNDX Syndax Pharmaceuticals | 14,52 | -1,11 | -7,10%